Search

Author/Creator Hayashi, M.

5. AB0377 Differences in Baseline Predictive Factors for Remission at 52 Weeks by Concomitant MTX Use during Tocilizumab Treatment Using Propensity Score Matched Groups. (15th July 2016)

Authors:
Kojima, T.; Asai, S.; Takahashi, N.; Yabe, Y.; Hirano, Y.; Kanayama, Y.; Kaneko, A.; Takemoto, T.; Asai, N.; Watanabe, T.; Funahashi, K.; Hayashi, M.; Ishiguro, N.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
1033
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. AB0485 Predictive Factors for Achievement of Low Disease Activity or Remission at 52 Weeks in Switching from TNF Inhibitors to Abatacept with Background of low Dose or no Methotrexate: A Multicenter Observational Cohort Study in Japan. (9th June 2015)

Authors:
Kojima, T.; Takahashi, N.; Kaneko, A.; Kida, D.; Hirano, Y.; Fujibayashi, T.; Yabe, Y.; Takagi, H.; Oguchi, T.; Miyake, H.; Kato, T.; Watanabe, T.; Hayashi, M.; Shioura, T.; Kanayama, Y.; Funahashi, K.; Asai, S.; Yoshioka, Y.; Terabe, K.; Takemoto, T.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 2
Page Start:
1059
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗